Peng Bing

Peng Bing

Deputy Director of the Pancreatic Surgery Ward, Director of the Shangjin Hepatobiliary and Pancreatic Minimally Invasive Center, Chief Physician, Professor, Doctoral Supervisor

Surgery
West China Hospital of Sichuan University logo Affiliated HospitalWest China Hospital of Sichuan University

Research areas : minimally invasive surgery for pancreatic tumors, biliary tract tumors, and complex hepatobiliary and pancreatic diseases; minimally invasive surgical treatment of pancreatic neck, body, and tail tumors, liver tumors, obstructive jaundice, and spleen-related diseases.

Cutting-edge technologies: laparoscopic pancreaticoduodenectomy with combined vascular reconstruction, PTCS minimally invasive treatment for complex biliary tract diseases; total laparoscopic pancreaticoduodenectomy (pioneer of the second wave in China, more than 1,000 cases); LPD with combined vascular resection and reconstruction (more than 150 cases, the most in the world); the world's first case of autologous transplantation of the round ligament of the liver for LPD, and fluorescence-guided laparoscopic pancreaticoduodenectomy with preservation of the duodenum.

Specializes in treating: pancreatic tumors, liver tumors, obstructive jaundice, spleen diseases, and hepatobiliary stones.

Academic Highlights: Fellow of the American College of Surgeons (FACS), member of the Laparoscopic and Endoscopic Surgery Group of the Surgical Branch of the Chinese Medical Association; chief editor of monographs such as "Laparoscopic Pancreatic Surgery" and "Minimally Invasive Pancreatic Surgery"; published 194 papers; led his team to achieve leading domestic and advanced international levels in minimally invasive pancreatic surgery. A pioneer in the promotion of laparoscopic pancreaticoduodenectomy in China, completing a large sample of LPD cases in China and promoting the nationwide popularization of minimally invasive pancreatic surgery.